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DNA-damage signaling utilizes a multitude
of posttranslational modifiers as molecular
switches to regulatecell-cycle checkpoints,DNA
repair, cellular senescence, and apoptosis.
Here we show that RNF8, a FHA/RING domain-
containing protein, plays a critical role in the
early DNA-damage response. We have solved
the X-ray crystal structure of the FHA domain
structure at 1.35 A˚. We have shown that RNF8
facilitates theaccumulationof checkpointmedi-
ator proteinsBRCA1and53BP1 to thedamaged
chromatin, on one hand through the phospho-
dependent FHA domain-mediated binding of
RNF8 to MDC1, on the other hand via its role in
ubiquitylating H2AX and possibly other sub-
strates at damage sites. Moreover, RNF8-de-
pleted cells displayed a defective G2/M check-
point and increased IR sensitivity. Together,
our study implicatesRNF8 as anovel DNA-dam-
age-responsive protein that integrates protein
phosphorylation and ubiquitylation signaling
and plays a critical role in the cellular response
to genotoxic stress.
INTRODUCTION
Faithful duplication and segregation of DNA is essential to
maintain genomic integrity during cell division. DNA le-
sions elicit a DNA-damage response, which collectively
includes DNA repair, activation of cell-cycle checkpoints,
chromatin remodeling, cellular senescence, and apopto-
sis. Mutations in a variety of components involved in theseCcellular processes directly contribute to tumorigenesis
(Bartkova et al., 2005; Gorgoulis et al., 2005), highlighting
the importance of these damage-induced signaling cas-
cades in tumor suppression. Accumulating evidence sug-
gests that the ATM/ATR-dependent phosphorylation of
histone variant H2AX to create g-H2AX is the initial signal
for subsequent accumulation of various mediators/repair
proteins to DNA lesions (Bassing et al., 2003; Celeste
et al., 2003). A positive feedback loop has been proposed
in which ATM/ATR concentrates at g-H2AX-containing
double-strand breaks via MDC1 to further phosphorylate
adjacent H2AX molecules and amplify the DNA-damage
signal (Lou et al., 2006; Stucki et al., 2005). Through this
signal amplification step, a number of mediator/repair
proteins, including BRCA1 and 53BP1, concentrate to
sites of DNA damage to facilitate downstream checkpoint
activation.
We and others have previously demonstrated that tan-
dem BRCT domains serve as phosphopeptide binding
motifs that mediate protein-protein interactions (Manke
et al., 2003; Yu et al., 2003). Specifically, a number of
DNA-damage response proteins, including BRCA1 and
MDC1 (Fernandez-Capetillo et al., 2002; Goldberg et al.,
2003; Lou et al., 2003a, 2003b; Stewart et al., 2003), harbor
BRCT domains that mediate binding to their respective
partners in a phosphorylation-dependent manner (Yu and
Chen, 2004; Stucki et al., 2005). In addition to tandem
BRCT domains, the FHA domain constitutes a separate
class of phosphopeptide binding modules (Durocher
et al., 2000). Many FHA domain-containing proteins have
been reported to play a role inDNA repair, cell-cycle arrest,
andpre-mRNAprocessing (Sun et al., 1998; Li et al., 2000).
The reversibility and sequence selectivity of ligand binding
afforded by these and other phosphopeptide binding do-
main-containing proteins allows individual protein-protein
interactions that control downstream responses to be
tightly regulated in a stimulus-dependent manner.ell 131, 901–914, November 30, 2007 ª2007 Elsevier Inc. 901
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Recent studies have provided additional insight into the
phosphorylation-dependent regulation of the DNA-dam-
age signaling network. However, the detailed mecha-
nisms by which the initial g-H2AX signal at DNA lesions
becomes propagated, amplified, andmodified to concen-
trate checkpoint mediator proteins to these sites remain
obscure. Here we report our study of an FHA and RING
domain-containing protein, RNF8, which serves as the
molecular linker for communication between the protein
phosphorylation and protein ubiquitylation pathways that
are crucial for the activation and maintenance of the
DNA-damage response.
RESULTS
RNF8 Is a DNA-Damage-Responsive Protein
We have previously studied the role of the FHA domain
and RING domain-containing protein Chfr in mitosis (Yu
et al., 2005). In the course of these studies we used a pro-
tein named RNF8 as a control because it is the only other
known mammalian protein that shares a similar domain
organization with Chfr (Figure S1A). RNF8 was initially
reported to interact with class III human ubiquitin-conju-
gating enzymes (E2s) through its RING domain (Ito et al.,
2001). RNF8 was later shown to bind to the Retinoid X
Receptor and regulate its transcriptional activity (Takano
et al., 2004). Because several FHA domain-containing
proteins are known to play a role in DNA-damage signal-
ing, we investigated whether RNF8 or Chfr might partici-
pate in the DNA-damage response. Cells stably express-
ing tagged RNF8 or Chfr were irradiated. Interestingly and
surprisingly, RNF8 foci can be readily observed after DNA
damage, and these foci colocalized with the DNA-damage
marker g-H2AX (Figure S1A). Despite the resemblance
of RNF8 and Chfr (Figure S1A), we did not observe any
Chfr focus formation following DNA damage (Figure 1A),
indicating that these two related proteins have distinct
cellular functions.
To confirm the observed IR-induced focus localization
of RNF8, we generated a polyclonal antibody specifically
recognizing RNF8 (Figure S1B). IR-induced foci (IRIF) of
endogenous RNF8 can be readily visualized (Figure 1B).
The fact that RNF8 foci overlap with those of g-H2AX
prompted us to speculate that RNF8 might function in
the DNA-damage response. We therefore examined the
localization of RNF8 with several proteins known to be
involved in this damage-induced signaling cascade. AsCexpected, RNF8 colocalizes with MDC1, NBS1, 53BP1,
BRCA1, pATM, and MCPH1, further lending credence to
the potential role of RNF8 in the DNA-damage response
(Figure S1C).
The DNA-damage-induced focus formation of check-
point proteins reflects their localization to chromatin struc-
tures at the vicinity of DNA breaks. Indeed, increased
amount of RNF8 accumulated in the acid extractable
fraction after IR treatment (Figure 1C). Moreover, the
less-soluble fraction of RNF8 can be released by nuclease
treatment (Figure 1D), suggesting that RNF8 accumulates
at the chromatin upon DNA damage. Together, our stud-
ies suggest that RNF8 is a novel DNA-damage-responsive
protein.
RNF8 Acts Downstream of H2AX and MDC1
following DNA Damage
It is generally accepted that the phosphorylation of histone
variant H2AX is the initial signal upon DNA lesion detec-
tion. g-H2AX is required for the sustained localization of
a number of DNA-damagemediator/repair factors at chro-
matin regions at or near the sites of DNA damage (Paull
et al., 2000). To delineate where RNF8 fits in the estab-
lished DNA-damage signaling cascade, we examined
IRIF formation of RNF8 in a number of human or mouse
cells with deficiencies in various DNA-damage checkpoint
proteins. Our anti-RNF8 antibody could not detect endog-
enous RNF8 in mouse embryonic fibroblasts (MEFs), so
we used retroviral particles containing a RNF8 expression
construct to infect these cells (Figure 1E). In sharp con-
trast to the control wild-type (WT) MEFs, no IR-induced
RNF8 focus formation was observed in H2AX-deficient
MEFs or those reconstituted with the S139A phosphomu-
tant (Figures 1E andS1D). Likewise, RNF8 focus formation
was also abrogated in MDC1-deficient cells. On the other
hand, RNF8 relocalization to g-H2AX-containing foci is not
noticeably affected in cells with BRCA1, 53BP1, or NBS1
deficiency (Figure 1E). These data suggest that RNF8 acts
downstream of H2AX and MDC1 in the DNA-damage-
responsive pathway.
The FHA, but Not Its RING Domain, Targets RNF8
to DNA Breaks
The FHA domain is a phosphoprotein-binding module
(Durocher et al., 2000; Li et al., 2000). Figure 1F shows
that tagged WT RNF8 formed foci that colocalize with
g-H2AX following IR treatment. Similarly, foci formationFigure 1. RNF8 Is Involved in Mammalian DNA-Damage Response
(A) Localization of tagged RNF8 and Chfr in response to IR. Cells expressing Myc-tagged RNF8 or Chfr were irradiated and immunostained with anti-
Myc and anti-pH2AX antibodies.
(B) Localization of endogenous RNF8 before and after IR treatment in 293T cells. Immunostaining experiments were performed using anti-RNF8 and
anti-pH2AX antibodies.
(C and D) RNF8 relocalizes to chromatin fraction after IR (C), which is reversible following micrococcal nuclease treatment (D). Procedures were
carried out as described in the Experimental Procedures and immunoblotting experiments were conducted using indicated antibodies.
(E) Genetic dependence of RNF8 relocalization following DNA damage. Deficient cells and their respective wild-type (WT) counterparts were infected
with retrovirus expressing Flag-tagged RNF8. Immunostaining experiments were performed using anti-Flag and anti-g-H2AX antibodies.
(F) The FHA domain, but not the RING domain, of RNF8 targets its localization to DNA-damage foci. Cells expressing Flag-tagged WT or mutants of
RNF8 were mock treated or irradiated and immunostaining was carried out using indicated antibodies.ell 131, 901–914, November 30, 2007 ª2007 Elsevier Inc. 903
can also be observed for the delRINGmutant. On the other
hand, the FHA deletion mutant (i.e., delFHA) failed to lo-
calize to g-H2AX-containing foci, suggesting that the
FHA domain of RNF8 is important for targeting RNF8 to
IR-induced DNA-damage sites (Figure S1E).
The FHA Domain of RNF8 Selects Phosphomotifs
Similar to Those Recognized by Tandem
BRCT Domains
FHA domains, like tandem BRCT domains, recognize
amino acid sequences extending 3–4 residues around
a central phosphorylated amino acid, with selection deter-
mined primarily by residues in the third C-terminal (+3)
position (Durocher et al., 2000). However, in contrast to
BRCT domains that recognize both pSer- and pThr-
containing sequences, FHA domains appear only to rec-
ognize pThr-containingmotifs. We determined the optimal
phosphopeptide motifs recognized by the RNF8 FHA
domain using pThr-oriented peptide library screening
(Figure 2A). Intriguingly, the RNF8 FHA domain showed
strong selection for Tyr and Phe in the +3 position. This
selection for aromatic amino acids differs substantially
from the acidic and aliphatic residue selection in the +3
position shown by all other FHA domains for which X-ray
crystal structures are available (Durocher et al., 2000; Li
et al., 2002). Instead, this selection for aromatic amino
acids at the +3 position closely resembles the optimal
phosphopeptide motifs recognized by the tandem BRCT
domains of BRCA1 and MDC1 (Manke et al., 2003; Stucki
et al., 2005; Yu et al., 2003).
To investigate the structural basis for this unusual motif
selection, we used limited proteolysis to map the bound-
aries of the FHA domain and solved the high-resolution
structure of the RNF8 FHA:optimal phosphopeptide com-
plex by X-ray crystallography at 1.35 A˚ (Table S1; the PDB
code for the RNF8 FHA domain is 2PIE). The global fold of
the RNF8 FHA domain is an 11-stranded b sandwich with
the phosphopeptide-binding surface comprised of resi-
dues in loops that connect the b-strands at one end of
the sandwich (Figure 2B), similar to what has been previ-
ously observed in the crystal structures of Rad53 and
Chk2 FHA domains (Durocher et al., 2000; Li et al.,
2002). The bound phosphopeptide is in an extended con-
formation with extensive contacts between the peptide
backbone and side chain and main chain atoms from
the RNF8 FHA domain (Figure 2C).
Three structural features observed in the RNF8 FHA:
phosphopeptide complex are distinct from those in other
FHA domains: First, the RNF8 FHA domain contains
two divergent loops and a C-terminal a-helical extension
that cluster along one face of the domain, well removed
from the phosphopeptide-interacting surface (Figure 2B,
shaded red). This region is likely involved in phospho-
independent interactions with potential substrates or
with additional portions of the full-length RNF8 molecule.
Second, the RNF8 FHA domain makes extensive direct
contacts to the phosphate group, including a novel biden-
tate interaction involving Arg61 that is not observed in any904 Cell 131, 901–914, November 30, 2007 ª2007 Elsevier Inc.other FHA domain:phosphopeptide crystal structure
(Figure 2D). Third, the selectivity for Tyr/Phe in the +3 po-
sition results from its interaction with a flat, mostly nonpo-
lar surface relatively enriched in sulfur-containing amino
acids (Cys55, Met58, Val110, and Leu112). Interestingly,
the general character of the interaction between the +3
Tyr and the surface of the RNF8 FHA domain is strikingly
similar to that observed between the +3 Tyr residue of
a g-H2AX pSer-containing phosphopeptide and the sur-
face of the tandem BRCT domains of MDC1 critical for
MDC1 foci formation (Figures 2E and 2F). On the other
hand, the RNF8 FHA domain +3 interacting surface bears
little resemblance to the analogous surfaces in other FHA
domains (Figures 2G and 2H). Thus, it appears that the
pThr-binding FHA domain of RNF8 has evolved to bind
to similar motifs as those recognized by the BRCT do-
mains of the foci-forming proteins BRCA1 and MDC1.
Phosphopeptide Binding by the FHA Domain
Is Required for RNF8 Foci Formation
We directly investigated whether phospho-dependent
binding was critical for IRIF formation of RNF8. We found
that mutation of Arg61 to Gln reduced FHA domain:phos-
phopeptide binding by over 160-fold (Figures S2A and
S2B). When the full-length RNF8 R61Q mutant protein
was introduced into cells, no R61Q foci were observed
after radiation damage (Figure S2C), indicating that phos-
pho-dependent binding is required for interaction be-
tween the RNF8 FHA domain and its upstream binding
partner.
In an experiment with cell lysates, WT RNF8 could be
pulled down with a phospho-Ser-containing peptide
derived from g-H2AX (Figure S2D) but not with the control
unphosphorylated peptide. This interaction was totally
abolished in experiments with the delFHA or R61Qmutant
proteins. Furthermore, consistent with the previous obser-
vation that Chfr does not form IRIF, Chfr did not bind to the
phosphorylated H2AX peptide (Figure S2E). Although
RNF8 bound to phospho-H2AX peptides in a pulldown
experiment, we failed to detect any direct binding be-
tween the RNF8 FHA domain and a phospho-H2AX pep-
tide by isothermal titration calorimetry (data not shown),
raising the possibility that the RNF8:g-H2AX interaction
observed was indirect. Because the BRCT domains of
MDC1 mediate its direct binding to phospho-H2AX, and
MDC1 is required for RNF8 IRIF, we examined whether
RNF8 interacts with MDC1. Intriguingly, the optimal motif
for phosphopeptide binding to the RNF8 FHA domain is
pTXXY/F (Figure 2A), and inspection of the MDC1 se-
quence reveals four potential ATM/ATR phophorylation
sites that match this motif (T699QCF, T719QAF, T752QPF,
and T765QPF). One of these TQPF sites was recently
reported to be phosphorylated following DNA damage in
a large-scale proteomic study (Matsuoka et al., 2007).
We therefore synthesized peptides containing each of
these four putative phosphorylation sites and measured
their binding to the RNF8 FHA domain. Three of the four
bound with affinities comparable to the optimal peptide
Figure 2. Structural Basis for Phosphorylation-Dependent Binding by RNF8 FHA Domain
(A) Amino acid selectivity values for the RNF8 FHA domain determined using the phosphothreonine-oriented degenerate peptide library MAXXXX-pT-
XXXXAKKK, where X indicates all amino acids except Cys. ValuesR 1.4 indicate moderate selection; valuesR 2.0 indicate strong selection.
(B) Cartoon representation of the RNF8 FHA domain bound to the optimal phosphopeptide ELKpTERY.
(C) stereo view of the phosphopeptide-binding surface.
(D) Closeup of the phosphate-binding pocket, with 2Fo-Fc density map contoured at 2s. A bound water molecule is evident in the upper center.
(E–G)Molecular interaction surfaces of the RNF8:phosphopeptide complex, theMDC1 tandemBRCT domain:g-H2AX phosphopeptide complex, and
the Rad53 FHA1:LEVpTEADphosphopeptide complex. Peptide surfaces are contoured in salmon, protein surfaces are contoured in lime. In the RNF8
FHA domain (E), selection for Tyr over Phe in the +3 position likely results from a water-mediated contact between the Tyr hydroxyl and the backbone
nitrogen of Leu57. In the Rad53 FHA1 structure (G), an Arg residue from the FHA domain occupies the equivalent position as the peptide +3 Tyr in the
RNF8 structure (dashed line).
(H) Divergence in the phospho-amino acid +3 binding surfaces of the FHA domains of RNF8 and Rad53. The Ca traces of the FHA domains of the
RNF8 FHA domain:phosphopeptide complex and the Rad53 FHA1 domain:phosphopeptide complex were optimally aligned. The phosphopeptide
+3 interacting region is shown in cartoon representation, with the RNF8 FHA domain shaded blue and its bound phosphopeptide shaded cyan, while
the Rad53 FHA1 domain is shaded yellow and its bound phosphopeptide is shaded green. The +3 Tyr residue in the RNF8 optimal phosphopeptide
and the +3 Asp in the Rad53 FHA1 optimal phosphopeptide are shown in stick representation. Note that the +3 Tyr binding site in RNF8 is occluded in
the Rad53 FHA domain by an Arg residue that mediates selection for Asp in the +3 position.Cell 131, 901–914, November 30, 2007 ª2007 Elsevier Inc. 905
Figure 3. RNF8 Is Localized to the Sites of DNA Damage via an FHA-Dependent Interaction with MDC1
(A) Schematic diagram showing full-length MDC1 (WT) and an internal deletion mutant (Del) of MDC1 that abolishes all four putative phosphorylation
sites.
(B) Coomassie staining of purified bacterially expressed GST-RNF8 protein.
(C) Full-length MDC1 but not the deletion mutant (Del) interacts with RNF8 in a pull-down assay. Lysates from 293T cells overexpressing Flag-tagged
MDC1 or its deletionmutant were incubatedwith GST-RNF8 fusion protein immobilized on the glutathione agarose beads for 2 hr before washing and
subsequent analysis by western blotting with anti-Flag antibody.
(D) MDC1 but not Del mutant of MDC1 coimmunoprecipitates with RNF8. 293T cells were cotransfected with plasmids encoding myc-tagged RNF8
and plasmids encoding SBP-Flag-MDC1 or its deletionmutant. Lysates were incubated with streptavidin beads for 2 hr at 4C. Thereafter beadswere
washed three times with NETN, and isolates were separated by SDS-PAGE and analyzed by western blotting with indicated antibodies.
(E) RNF8 interacts with MDC1 via its FHA domain. Experiments were conducted similarly to that described in (D) and immunoprecipitation and
immunoblotting were carried out as indicated.
(F) 293T cells were irradiated (10 Gy; 1 Gy = 100 Rads) or left untreated and cell extract (NETN + 500 mM NaCl) was treated with or without lambda
phosphatase prior to diluting and incubating with bacterially expressed 10 mg of GST-RNF8 protein for 2 hr at 4C . The GST-RNF8 complex was
separated by SDS-PAGE to evaluate the amount of endogenous MDC1 that bound specifically to RNF8.(Figures S2F–S2I), while the fourth bound more weakly.
We next generated a deletion mutant spanning residues
698–768 (Del) of MDC1 (Figure 3A) and showed that
MDC1, but not Del, specifically bound to purified GST-
RNF8 (Figures 3B and 3C). In addition, RNF8 coprecipi-
tated with WT but not Del mutant of MDC1 in vivo
(Figure 3D), further implying that these putative phosphor-906 Cell 131, 901–914, November 30, 2007 ª2007 Elsevier Inc.ylation sites are required for the interaction between RNF8
andMDC1. A control experiment using the delFHAmutant
of RNF8 confirms that this interaction also requires the
FHA domain of RNF8 (Figure 3E). Similar results were
obtained in reciprocal immunoprecipitation assays. Con-
sistent with the role of MDC1 in mediating RNF8 accu-
mulation at DNA-damage sites, an increased amount of
MDC1 bound to RNF8 after IR, and this MDC1 was
abolished with prior phosphatase treatment (Figure 3F).
Likewise, WT but not Del mutant of MDC1 restored RNF8
IRIF inMDC1-depletedHeLacells (FiguresS3A–S3B).Col-
lectively, these in vitroand invivo results support apossible
direct role of MDC1 in facilitating RNF8 localization, via
a phospho-specific interaction conferred by the RNF8
FHA domain, to the chromatin following DNA damage.
Both the RNF8 FHA and RING Domains Are
Required for BRCA1 and 53BP1 IRIF
To further probe the role of RNF8 at DNA-damage sites
in vivo, we depleted RNF8 with two different siRNAs and
tested whether the IRIF of a number of mediator/repair
proteins were RNF8 dependent. RNF8 knockdown did
not affect g-H2AX or MDC1 foci formation at DNA-dam-
age sites (Figures 4A and S4A–S4C); however, localization
of 53BP1 and BRCA1 to foci was abrogated (Figure 4A),
suggesting that RNF8 lies upstream of these DNA-dam-
age signaling mediator/effectors and facilitates the accu-
mulation of these proteins to the sites of DNA damage.
The MDC1/RNF8 interaction experiments presented in
Figure 3 imply that MDC1 may interact with RNF8 and
regulate RNF8-dependent events following DNA damage.
MDC1 was previously shown to be required for IRIF for-
mation of these checkpoint mediator proteins (Goldberg
et al., 2003; Lou et al., 2003a; Stewart et al., 2003; also
see Figure S4D). Here, we examined whether the MDC1/
RNF8 interaction is crucial for these events in vivo. As
expected, ectopically expressed MDC1 restored the
accumulation of BRCA1 and 53BP1 in response to IR in
MDC1/ MEFs. The MDC1 deletion mutation, which
abolishes its interaction with RNF8, did not affect its
own focus localization following IR but failed to restore
the RNF8-dependent concentration of BRCA1 and 53BP1
at the foci (Figure 4B), suggesting that the MDC1/RNF8
interaction is likely to be required for RNF8-dependent
functions following DNA damage.
In order to further explore roles of the RNF8 FHA and
RING domains in targeting 53BP1 and BRCA1 to foci,
we knocked down RNF8 in HeLa cells using siRNF8#2
(Figure S4E) and reintroduced full-length RNF8, delFHA,
or delRING using constructs containing silent mutations
within the RNF8 coding sequence that rendered the rein-
troduced constructs resistant to the siRNA. Unlike the de-
letion mutants, reconstitution with full-length RNF8
restored 53BP1 and BRCA1 IRIF in cells depleted of en-
dogenous RNF8 (Figures 4C and S4F). Thus, both the
phosphopeptide-binding and the ubiquitin ligase activity
of RNF8 are required for its function inmediating the accu-
mulation of DNA-damage checkpoint proteins at the sites
of DNA damage.
RNF8 Mediates IR-Induced Damage-Associated
Ubiquitin Conjugates
Our observation that IRIF formation of BRCA1 and 53BP1
requires the RNF8 RING domain suggests that the accu-
mulation of these checkpoint proteins is dependent onCeprotein ubiquitylation at the site of the damaged chroma-
tin. The finding that DNA-damage-associated ubiquitin
conjugates can be visualized using the anti-ubiquitin
FK2 antibody (Morris and Solomon, 2004; Polanowska
et al., 2006) is consistent with this hypothesis. If RNF8 is
involved in the ubiquitylation of proteins at the damaged
chromatin, H2AX and MDC1 deficiencies, which abrogate
RNF8 accumulation at IRIF, might be expected to disrupt
damage-dependent FK2 focus formation. This is indeed
the case (see Figures S5A–S5C). Recently, the E2 ubiqui-
tin-conjugating enzyme UBC13 was also implicated in the
ubiquitylation of protein(s) at the chromatin following DNA
damage (Zhao et al., 2007). However, the E3 ligase, which
provides substrate specificity, has yet to be identified.
That RNF8 was demonstrated to interact with UBC13 for
substrate ubiquitylation (Plans et al., 2006) prompted us
to speculate that RNF8 and UBC13 might act in concert
in the DNA-damage-signaling cascade. In support of this
speculation, we found that damage-associated ubiquitin
conjugates were absent in either RNF8-depleted or
UBC13-depleted cells (Figures 5A and S5D). UBC13 de-
pletion also suppressed the accumulation of 53BP1 and
BRCA1 at IRIF but did not affect focus formation of phos-
pho-H2AX and MDC1 (Figure S5E). In addition, RNF8 IRIF
can be readily visualized in UBC13-depleted cells, indicat-
ing that the damage-dependent RNF8 localization pre-
cedes UBC13 function in the DNA-damage response.
These data, together with previous reports, imply that
RNF8 acts with UBC13 to exert a mediator role in the
DNA-damage-signaling cascade.
RNF8 Mediates Accumulation of the UIM-
Containing Protein Rap80 at Sites of DNA Breaks
The ubiquitin-interacting motif (UIM) containing protein
Rap80 has recently been shown to relocalize to g-H2AX-
containing foci in a UIM-dependent manner (Kim et al.,
2007; Sobhian et al., 2007; Wang et al., 2007). We found
that Rap80 focus formation was abolished in RNF8-
depleted and UBC13-depleted cells (Figure 5B), and that
its localization requires both the RING and FHA domains
of RNF8 (Figures 5C and 5D). Together these results
strongly suggest that the ubiquitin conjugates, whose
appearance at foci we have shown to be dependent on
both RNF8 and UBC13, might serve as a signal for Rap80
accumulation at the sites of DNA damage.
RNF8 Is Required for H2AX Ubiquitylation
following DNA Damage
Because H2AX phosphorylation is essential for sustained
accumulation of MDC1 and RNF8, which in turn is re-
quired for localization of other checkpoint proteins includ-
ing the Rap80-BRCA1 complex and 53BP1 at DNA-dam-
age sites, we speculate that H2AX might be ubiquitylated
in a RNF8-dependent manner. We first examined whether
H2AX can be ubiquitylated in vivo. By overexpressing
tagged H2AX and ubiquitin in the cell, we found that
some of the tagged H2AX molecules were ubiquitylated
(Figure 6A). Moreover, in HeLa cells stably expressingll 131, 901–914, November 30, 2007 ª2007 Elsevier Inc. 907
908 Cell 131, 901–914, November 30, 2007 ª2007 Elsevier Inc.
Figure 5. RNF8 Functions in Concert with UBC13 and Is Important for IR-Induced DNA-Damage-Associated Ubiquitin Conjugates
(A) HeLa cells depleted of endogenous RNF8 or UBC13 were irradiated (10 Gy) and immunostained with FK2 and g-H2AX antibodies.
(B) IRIF of UIM-containing protein Rap80 is dependent on RNF8 and UBC13.
(C) IRIF of damage-associated ubiquitin and (D) Rap80 foci formation requires RNF8 FHA and RING domains. HeLa cells infected with virus express-
ing siRNA-resistant full-length RNF8, delFHA, or delRINGwere transiently transfected with siRNF8#2 to deplete endogenous RNF8. Forty-eight hours
after the second transfection, cells were fixed and immunostained with indicated antibodies.HA-tagged H2AX, we showed that H2AX ubiquitylation is
regulated in an IR-dependent manner in vivo, and that
depletion of RNF8 abolishes the IR-induced H2AX ubiqui-
tylation. Because of the pivotal role phosphorylated H2AX
plays in the localization of checkpoint proteins at IRIF, we
used an antibody against g-H2AX to examine the state of
H2AX ubiquitylation specifically in the phosphorylated
form. While RNF8 deficiency does not affect IR-induced
H2AX phosphorylation, slower migrating bands corre-
sponding to ubiquitylated endogenous g-H2AX species
were observed in irradiated cells expressing RNF8 but
were compromised in the RNF8 knockdown cells (Fig-
ure 6C). While RNF8 is clearly responsible for g-H2AX
di-ubiquitylation, RNF8 knockdown also appears to lowerCethe levels of g-H2AX monoubiquitylation. Downregulation
of UBC13 also significantly reduced damage-induced
ubiquitylation of g-H2AX (Figure S6C), supporting our hy-
pothesis that RNF8 acts with UBC13 in promoting protein
ubiquitylation at or near DNA-damage sites. In control
experiments we have shown that our anti-phospho-
H2AX antibody specifically recognizes phosphorylated
H2AX species following DNA damage (Figures 6D and
6E). Together, these results point to a role for RNF8 in
regulating g-H2AX ubiquitylation in response to DNA
damage.
Because H2AX phosphorylation is critical for RNF8 lo-
calization to sites of DNA breaks (Figure S1D), we asked
whether H2AX ubiquitylation is similarly compromised inFigure 4. RNF8 Is Required for Accumulation of BRCA1 and 53BP1 at the Sites of DNA Damage
(A) HeLa cells were transfected twice with either RNF8 siRNAs or a nontargeting control siRNA. Forty-eight hours after the second transfection, cells
were treated with 10 Gy IR and recovered for 6 hr before they were fixed and permeabilized. Immunostaining experiments were performed as
described in the Experimental Procedures.
(B) 53BP1 and BRCA1 IRIF formation are restored in MDC1-deficient cells reconstituted with full-length MDC1 but not with the deletion mutant of
MDC1. Expression constructs encoding HA-tagged MDC1 (WT) or its deletion mutant (Del) were transiently transfected into MDC1-deficient
MEFs. Twenty-four hours post-transfection, cells were irradiated (10 Gy) and immunostained with indicated antibodies.
(C) HeLa cells depleted of endogenous RNF8 using siRNA#2 were infected with viruses encoding siRNA-resistant WT, delFHA, or delRING mutant of
RNF8. Infected cells were then irradiated and processed as described above to visualize protein localization as indicated.ll 131, 901–914, November 30, 2007 ª2007 Elsevier Inc. 909
Figure 6. RNF8 Is Required for H2AX Ubiquitylation following DNA Damage
(A) H2AX is ubiquitylated in vivo. 293T cells were transiently transfected with plasmids encoding myc-tagged ubiquitin with or without plasmids
encoding SBP-Flag-H2AX. Immunoprecipitation and immunoblotting were carried out using indicated antibodies. Black arrow indicates doubly
ubiquitylated species of H2AX, while gray arrow indicates monoubiquitinated H2AX. Multiple-ubiquitinated H2AX species are also pointed out.
(B) HeLa cells stably expressing HA-tagged H2AX were transfected with control siRNA or RNF8 siRNA were treated with 10 Gy or left untreated. Cells
were harvested 1 hr post-irradiation. Cell lysates were prepared, separated by SDS-PAGE, and blotted with indicated antibodies.
(C) HeLa cells transfected with control siRNA or RNF8 siRNAwere treated as described in (B) and immunoblotting experiments were carried out using
indicated antibodies.
(D) IR-induced H2AX ubiquitylation in H2AX+/+ and H2AX/MEFs. Cell lysates prepared from WT or H2AX/ cells before and after irradiation were
immunoblotted with anti-H2AX and anti-pH2AX antibodies.
(E) IR-induced H2AX ubiquitylation requires H2AX phosphorylation. H2AX-deficient MEFs stably expressing HA-tagged H2AX or S139A mutant of
H2AX were treated with 0 Gy or 10 Gy and immunoblotting was performed using indicated antibodies.
(F) IR-induced H2AX ubiquitylation requires RNF8 FHA and RING domains. Experiments were carried out as that described in Figure 4C. Immuno-
blotting experiments were conducted with antibodies as indicated. Arrow indicates ubiquitylated species of H2AX that only appear after radiation in
cells expressing WT RNF8.910 Cell 131, 901–914, November 30, 2007 ª2007 Elsevier Inc.
Figure 7. RNF8 Is Required for G2/M
Checkpoint Control and Cell Survival
following Ionizing Radiation
(A) IR-induced G2/M checkpoint is defective in
cells with RNF8 depletion and requires both the
RNF8 FHA and RING domains. A summary of
the percentages of cells stained positive with
phospho-H3 antibody before and after IR treat-
ment from three individual experiments is
shown. Error bars indicate standard deviation.
HeLa cells were transfected with indicated siR-
NAs, and percentages of mitotic cells before
and after radiation were determined by FACS
analysis as described in Experimental proce-
dures.
(B) RNF8-depleted cells display increased
radiation sensitivity as determined by colony
formation assay. Figure represents value ob-
tained from three separate experiments, each
performed in triplicate. Error bars indicate
standard deviation.
(C) A proposed model of the DNA-damage-
responsive pathway involving RNF8. The relo-
calization of the Rap80-BRCA1 complex and
53BP1 requires RNF8-dependent protein ubiq-
uitylation at the chromatin, whereas the accu-
mulation of NBS1 at DNA-damage sites is
independent of RNF8.cells expressing a nonphosphorylatable S139A H2AX
mutant protein. Indeed, only H2AX-deficient MEFs recon-
stituted with WT H2AX, but not those reconstituted with
the H2AX S139A mutant, supported damage-dependent
H2AX ubiquitylation (Figure 6E). Similarly, the RNF8-
dependent H2AX ubiquitylation is also compromised in
MDC1-deficient cells (Figure S6A).
We also reconstituted H2AX/ cells with H2AX K119/
120R mutant. While this H2AX mutant abolished the con-
stitutive monoubiquitylation of H2AX, cells expressing this
mutant still showed damage-induced formation of ubiqui-
tin conjugates and IR-induced H2AX ubiquitylation (Fig-
ures S6D and S6E), suggesting that IR-induced H2AX
ubiquitylation is distinct from those constitutively mono-
ubiquitylated H2AX species.
To further evaluate whether the chromatin-associated
RNF8 phosphopeptide-binding and E3 ligase activities
are required for H2AX ubiquitylation in response to IR,
RNF8-depleted HeLa cells expressing siRNA-resistant
full-length delFHA or delRING versions of RNF8 were
examined. As shown in Figure 6F, IR-induced H2AX ubiq-
uitylation required both the FHA and RING domains of
RNF8.
RNF8 Participates in the G2/M Checkpoint and
Loss of RNF8 Renders Cells Sensitive
to Ionizing Radiation
DNA-damage checkpoints have evolved to maintain ge-
nomic stability by preventing cells with damaged DNA
from entering mitosis. Because RNF8 enables the accu-
mulation of multiple checkpoint proteins at the sites of
DNA breaks, we tested the effect of RNF8 in IR-induced
cell-cycle arrest. While cells transfected with controlCsiRNA displayed normal checkpoint activation, RNF8-
depleted cells, like those depleted of BRCA1, failed to
properly arrest at the G2/M checkpoint upon IR (Figures
7A and S7A). Moreover, restoration of the G2/M check-
point required reintroduction of full-length RNF8 in
RNF8-depleted cells (Figures 7B and S7B). Finally, deple-
tion of RNF8 also resulted in a notable increase in IR sen-
sitivity (Figures 7B and S7C), further supporting a role of
RNF8 in cellular response to DNA damage.
DISCUSSION
In this study, we have uncovered a novel role of RNF8 in
the DNA-damage response. Our data strongly suggest
that RNF8 channels the initial phosphorylation-dependent
marks at DNA lesions to promote the accumulation of
multiple checkpoint proteins, including Rap80, BRCA1,
and 53BP1, which, in turn, contribute to RNF8’s putative
role in maintaining genome integrity. As an E3 ubiquitin
ligase, RNF8 promotes protein ubiquitylation at sites of
DNA breaks.
In eukaryotic cells where DNA is tightly packed, the
chromatin structure impedes many of the activities that
require access to the genetic materials. Despite our un-
derstanding of the roles of H2AX phosphorylation in the
DNA-damage response, it has only become evident
recently that chromatin remodeling and other histone
modifications also play important functions in this cellu-
lar process. Specifically, a role of the ATP-dependent
chromatin-remodeling complexes, such as the INO80,
SWR1, RSC, and SWI/SNF, and histone acetyltransferase
complexes including the Trrap-Tip60 complex have been
implicated in DNA repair (Murr et al., 2006; Tsukuda et al.,ell 131, 901–914, November 30, 2007 ª2007 Elsevier Inc. 911
2005). However, unlike those catalyzed by the Trrap-Tip60
complex, the impaired loading of DNA checkpoint
proteins observed in RNF8-depleted cells could not be
counteracted by preincubation with sodium butyrate,
chloroquine, or hypotonic solution (unpublished data).
We hypothesize that RNF8 may be required for the ac-
cumulation of checkpoint/repair proteins via a different
mechanism, i.e., ubiquitylating proteins at the sites of
DNA breaks. Indeed, RNF8 is pivotal for the accumulation
of ubiquitin conjugates at the damaged chromatin, which
depended on its FHA and RING domains. In support of the
role of RNF8 in protein ubiquitylation at sites of DNA
breaks, we show that the phosphorylation-dependent
RNF8 accumulation at g-H2AX sites is responsible for
the IR-induced H2AX di-ubiquitylation. The E3 ligase
complex BRCA1-BARD1 has also been shown to catalyze
ubiquitin polymers at the damaged chromatin (Morris and
Solomon, 2004; Polanowska et al., 2006; Yu et al., 2006).
However, unlike RNF8 and UBC13, BRCA1 depletion did
not compromise the IR-induced H2AX ubiquitylation
(Figure S6B), suggesting that BRCA1 accumulates at the
sites of DNA breaks subsequent to the RNF8/UBC13-
dependent H2AX ubiquitylation following DNA damage.
Finally, we found that ubiquitylation events catalyzed by
RNF8 are independent of H2AX K119 and K120, illustrat-
ing that damage-induced H2AX ubiquitination is RNF8
dependent but distinct from the constitutive monoubiqui-
tylation of H2AX (Figures S6D and S6E).
A scenario is now emerging in which ubiquitination
serves as a posttranslational modifier in the DNA-dam-
age-dependent signaling cascade (Huang and D’Andrea,
2006). Recent studies suggest a role of histone ubiquitina-
tion as a means to remodel the chromatin in order to facil-
itate the accumulation of DNA repair protein (Kapetanaki
et al., 2006; Wang et al., 2006). In addition, monoubiquity-
lation of a number of proteins has been demonstrated to
be responsible for protein-protein interactions (Garcia-
Higuera et al., 2001; Matsushita et al., 2005; Pavri et al.,
2006; Stelter andUlrich, 2003; Taniguchi et al., 2002). Mul-
tiple ubiquitin moieties covalently attached via lysine 63
have also been reported to regulate and promote the
accumulation of proteins involved in DNA repair (Hoege
et al., 2002; Hofmann and Pickart, 1999). More recently,
the UIM-containing protein Rap80 was discovered to
play a role in the BRCA1-dependent DNA-damage re-
sponse, serving as an adaptor for BRCA1 accumulation
at sites of DNA breaks (Kim et al., 2007; Sobhian et al.,
2007; Wang et al., 2007). Our observation that RNF8 me-
diates both the IRIF of conjugated ubiquitin and Rap80 at
sites of DNA breaks implies that Rap80 might associate
with the damaged chromatin by tethering to certain FK2-
reacting ubiquitylated protein(s). The fact that the IR-
induced H2AX ubiquitylation is similarly compromised in
RNF8-depleted cells implicates H2AX as an RNF8 sub-
strate. In the accompanying paper, in addition to H2AX,
H2A has also been shown to be a substrate of RNF8 (Mai-
land et al., 2007). Together these studies support a model
that ubiquitin chains on H2A, H2AX, and probably other912 Cell 131, 901–914, November 30, 2007 ª2007 Elsevier Inc.RNF8 substrates might serve as important docking sites
during the transduction of the DNA-damage signal.
While the UIM-containing protein RAP80 is required for
BRCA1 localization, RAP80 is dispensable for 53BP1
localization. It would be interesting to test whether any
additional ubiquitin-binding protein would serve to tether
53BP1 to DNA-damage sites via damage-associated
ubiquitin conjugates. Given the role of histone ubiquityla-
tion in chromatin remodeling, it is also plausible that the
RNF8-dependent ubiquitylation events at the vicinity of
DNA breaks may enhance the accessibility of 53BP1 to
modified histones (Huyen et al., 2004; Sanders et al.,
2004; Botuyan et al., 2006). In any case, based on the
requirement of the RNF8 RING domain, we propose that
RNF8 facilitates the transduction of the initial phosphory-
lation-dependent DNA lesion signal by regulating H2A/
H2AX ubiquitylation, and possibly other substrates, and
thus controlling the localization of the Rap80-BRCA1
complex and other checkpoint proteins.
In summary, our study implies a critical role of the E3
ubiquitin ligase RNF8 in supporting genome integrity by
licensing the assembly of multiple checkpoint/DNA repair
proteins at DNA lesions. The link between protein phos-
phorylation and ubiquitylation revealed in this study high-
lights the importance of posttranslational modifiers as
molecular switches that govern, among many cellular
processes, the DNA-damage response pathway in a stim-
ulus-inducible manner. RNF8 is a key player involved in
the crosstalk between different protein modifications,
with its FHA domain required for its localization to DNA-
damage foci through a phosphorylation-dependent inter-
action and its E3 ligase catalytic domain required for the
further accumulation of Rap80, BRCA1, and 53BP1 (Fig-
ure 7F). The interplay between these two protein modifica-
tion cascades may play an essential role in ensuring the
proper execution of cellular response to DNA damage.
EXPERIMENTAL PROCEDURES
Antibodies
The RNF8 polyclonal antibody was raised against a GST-RNF8 fusion
protein and was affinity purified using an MBP-RNF8 column. Anti-
bodies against the myc epitope, H2AX, g-H2AX, BRCA1, MDC1, and
53BP1, were previously described (Lou et al., 2003b; Yu et al.,
2006). The anti-H3, anti-FK2, and anti-ORC2 antibodies were obtained
from Upstate Cell Signaling. Anti-pATM (Ser1981), anti-GAPDH, anti-
HA, and anti-UBC13 antibodies were purchased from Calbiochem,
Chemicon, Covance, and Anaspec, respectively. Anti-actin and anti-
Flag (M2) were obtained from Sigma.
Cell Culture and Transfection
293T cells were cultured in RPMI 1640 supplementedwith 5% fetal calf
serum (FCS), 5% bovine serum and 100 U/ml penicillin, and 100 mg/ml
streptomycin andmaintained in 5%CO2 at 37
C. Cell transfection was
performed using Lipofectamine 2000 (Invitrogen) following manufac-
turer’s protocol.
Immunostaining Procedure
To visualize IRIF, cells cultured on coverslips were treated with 10 Gy
IR (1 Gy = 100 Rads) followed by recovery for 6 hr. Cells were then
washed with PBS, incubated in 3% paraformaldehyde for 12 min,
and permeabilized in 0.5% triton solution for 5 min at room tempera-
ture. Samples were blocked with 5% goat serum and incubated with
primary antibody for 60 min. Samples were washed and incubated
with secondary antibody for 60 min. Cells were then stained with
DAPI to visualize nuclear DNA. The coverslips were mounted onto
glass slides with anti-fade solution and visualized using a Nikon
ECLIPSE E800 fluorescence microscope.
IR Sensitivity, G2/M Checkpoint Assays,
and Chromatin Fractionation
IR sensitivity and G2/M checkpoint assays were performed as de-
scribed previously (Lou et al., 2003b). Preparation of chromatin frac-
tions were described previously with modifications (Yu et al., 2006).
Briefly, cells were harvested at indicated times after treatment and
washed once with PBS. Cell pellets were subsequently resuspended
in low-salt permeabilization buffer (10 mM HEPES pH 7.4, 10 mM
KCl, 0.05% NP-40, and protease inhibitors) and incubated on ice for
10 min. Thereafter, nuclei were recovered and resuspended in 0.2M
HCl. The soluble fraction was neutralized with 1 M Tris-HCl pH 8.0
for further analysis. For microccocal nuclease (MNase) treatment, nu-
clei recovered after low-salt extraction was washed and resuspended
in nuclease reaction buffer (10 mMHEPES pH 7.4, 10 mMKCl, 0.5 mM
MgCl2, 2 mM CaCl2). Ten units of nuclease was added and incubated
for 30 min on ice. Thereafter, the insoluble fraction was treated essen-
tially as above to isolate the chromatin-bound proteins.
Supplemental Data
Supplemental Data include Supplemental Experimental Procedures,
Supplemental References, seven figures, and one table and can be
found with this article online at http://www.cell.com/cgi/content/full/
131/5/901/DC1/.
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